Living Donor Liver Transplant for Malignancy
David A. Axelrod(Northwestern University), Michaël Abécassis(University of Arizona), Mary F. Mulcahy(Northwestern University), Patrice Al‐Saden(Northwestern University), Laura Kulik(Northwestern University), Alan J. Koffron(Toho University), Jonathan P. Fryer(Northwestern University), Talia Baker(University of Utah)
Cited by 32
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
|Liver Transplantation|2010|1.2k